Heart failure with preserved ejection fraction: uncertainties and dilemmas

Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction: Contributions of Collagen and Titin

(2015) M. R. Zile et al.   CIRCULATION

Meta-Analysis of the Effect of Statins on Mortality in Patients With Preserved Ejection Fraction

(2014) Gang Liu et al.   AMERICAN JOURNAL OF CARDIOLOGY

Right Ventricular Function in Heart Failure With Preserved Ejection Fraction

(2014) Selma F. Mohammed et al.   CIRCULATION

Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection Fraction

(2014) Natalie A. Bello et al.   Circulation-Heart Failure

Wireless Pulmonary Artery Pressure Monitoring Guides Management to Reduce Decompensation in Heart Failure With Preserved Ejection Fraction

(2014) Philip B. Adamson et al.   Circulation-Heart Failure

Right heart dysfunction in heart failure with preserved ejection fraction

(2014) Vojtech Melenovsky et al.   EUROPEAN HEART JOURNAL

New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes

(2014) M. Senni et al.   EUROPEAN HEART JOURNAL

Heart failure with preserved ejection fraction: a clinical dilemma

(2014) M. Komajda et al.   EUROPEAN HEART JOURNAL

Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES)

(2014) Burkert Pieske et al.   EUROPEAN JOURNAL OF HEART FAILURE

Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve)

(2014) Michael Böhm et al.   EUROPEAN JOURNAL OF HEART FAILURE

Beta-blockers in heart failure with preserved ejection fraction: a meta-analysis

(2014) Chirag Bavishi et al.   HEART FAILURE REVIEWS

In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry

(2014) Michele Senni et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The pathophysiology of heart failure with preserved ejection fraction

(2014) Barry A. Borlaug   Nature Reviews Cardiology

Lessons from the TOPCAT Trial

(2014) John J.V. McMurray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Spironolactone for Heart Failure with Preserved Ejection Fraction

(2014) Bertram Pitt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical Trials in Patients with Heart Failure and Preserved Left Ventricular Ejection Fraction

(2014) John G.F. Cleland et al.   Heart Failure Clinics

HFNEF, HFpEF, HF-PEF, or DHF

(2014) John E. Sanderson   JACC-Heart Failure

Developing Therapies for Heart Failure With Preserved Ejection Fraction

(2014) Javed Butler et al.   JACC-Heart Failure

Natural History of Left Ventricular Ejection Fraction in Patients With Heart Failure

(2013) Christina L. Clarke et al.  

Longitudinal Changes in Left Ventricular Stiffness

(2013) Barry A. Borlaug et al.   Circulation-Heart Failure

Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND

(2013) F. P. Brouwers et al.   EUROPEAN HEART JOURNAL

How do patients with heart failure with preserved ejection fraction die?

(2013) Michelle M.Y. Chan et al.   EUROPEAN JOURNAL OF HEART FAILURE

Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction

(2013) Margaret M. Redfield et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of If-Channel Inhibition on Hemodynamic Status and Exercise Tolerance in Heart Failure With Preserved Ejection Fraction

(2013) Wojciech Kosmala et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

(2013) Walter J. Paulus et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

RAnoLazIne for the Treatment of Diastolic Heart Failure in Patients With Preserved Ejection Fraction

(2013) Lars S. Maier et al.   JACC-Heart Failure

Prevalence, Clinical Phenotype, and Outcomes Associated With Normal B-Type Natriuretic Peptide Levels in Heart Failure With Preserved Ejection Fraction

(2012) Venkatesh Y. Anjan et al.   AMERICAN JOURNAL OF CARDIOLOGY

Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction

(2012) Loek van Heerebeek et al.   CIRCULATION

Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction

(2012) Jan-Christian Reil et al.   EUROPEAN HEART JOURNAL

Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study

(2012) Christian Malchau Carlsen et al.   EUROPEAN JOURNAL OF HEART FAILURE

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

(2012) et al.   EUROPEAN JOURNAL OF HEART FAILURE

Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel?

(2012) Dirk J. van Veldhuisen et al.   EUROPEAN JOURNAL OF HEART FAILURE

High prevalence of undetected heart failure in long-term care residents: findings from the Heart Failure in Care Homes (HFinCH) study

(2012) Helen C. Hancock et al.   EUROPEAN JOURNAL OF HEART FAILURE

What Have We Learned About Patients With Heart Failure and Preserved Ejection Fraction From DIG-PEF, CHARM-Preserved, and I-PRESERVE?

(2012) Ross T. Campbell et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of Endurance Training on the Determinants of Peak Exercise Oxygen Consumption in Elderly Patients With Stable Compensated Heart Failure and Preserved Ejection Fraction

(2012) Mark J. Haykowsky et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial

(2012) Scott D Solomon et al.   LANCET

Prevalence and Significance of Alterations in Cardiac Structure and Function in Patients With Heart Failure and a Preserved Ejection Fraction

(2011) Michael R. Zile et al.   CIRCULATION

Mortality in heart failure with preserved ejection fraction: an unacceptably high rate

(2011) D. Burkhoff   EUROPEAN HEART JOURNAL

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis

(2011)   EUROPEAN HEART JOURNAL

Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure

(2011) Jasper W.L. Hartog et al.   EUROPEAN JOURNAL OF HEART FAILURE

Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction

(2010) Michael R. Zile et al.   CIRCULATION

Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction

(2010) Dirk Westermann et al.   Circulation-Heart Failure

Heart Rate Predicts Mortality in Patients With Heart Failure and Preserved Systolic Function

(2010) John R. Kapoor et al.   JOURNAL OF CARDIAC FAILURE

Baseline Plasma NT-proBNP and Clinical Characteristics: Results From the Irbesartan in Heart Failure With Preserved Ejection Fraction Trial

(2009) Robert S. Mckelvie et al.   JOURNAL OF CARDIAC FAILURE

Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease

(2009) Nicola C. Edwards et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Sildenafil Stops Progressive Chamber, Cellular, and Molecular Remodeling and Improves Calcium Handling and Function in Hearts With Pre-Existing Advanced Hypertrophy Caused by Pressure Overload

(2009) Takahiro Nagayama et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction

(2009) Dirk J. van Veldhuisen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Central obesity: Association with left ventricular dysfunction and mortality in the community

(2008) Khawaja Afzal Ammar et al.   AMERICAN HEART JOURNAL

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

(2008) GISSI-HF investigators   LANCET

Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

(2008) Barry M. Massie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diastolic Stiffness of the Failing Diabetic Heart

(2007) Loek van Heerebeek et al.   CIRCULATION